Gina Lundberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gina Lundberg has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Laxmi S. Mehta
The Ohio State University, 410 West 10th Avenue, Columbus, OH 43210, USA
3 shared publications- Laxmi S. Mehta
Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA
3 shared publications - Mamas Andreas Mamas
Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, United Kingdom; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, United Kingdom
3 shared publications - Ritu Thamman
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
3 shared publications Sindhu Prabakaran
Emory University School of Medicine, Department of Medicine, Atlanta, Georgia
3 shared publicationsAnnabelle S. Volgman
Rush University Medical Center, Chicago, IL (R.M.S., H.N.P., N.T.A., L.T.B., A.S.V.).
2 shared publications
Latest Publications
- 26 October 2026
- Published by Wolters Kluwer Health in Circulation
Promises to Keep: Closing the Gaps in Women’s Cardiovascular Health
- 26 October 2026
- Published by Wolters Kluwer Health in Circulation
Promises to Keep: Closing the Gaps in Women’s Cardiovascular Health
- 26 October 2025
- Published by Elsevier in Endocrine Practice
- Vol. 31 (12) , 1642-1648
Menopause Hormone Therapy: 30 Years of Advances and Controversies
- 26 October 2025
- Published by Elsevier in Endocrine Practice
- Vol. 31 (12) , 1642-1648
Menopause Hormone Therapy: 30 Years of Advances and Controversies
- Open Access
- 18 April 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (8)
Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
Racial disparities in cardiovascular disease are unjust, systematic, and preventable. Social determinants are a primary cause of health disparities, and these include factors such as structural and overt racism. Despite a number of efforts implemented over the past several decades, disparities in cardiovascular disease care and outcomes persist, pervading more the outpatient rather than the inpatient setting, thus putting racial and ethnic minority groups at risk for hospital readmissions. In this article, we discuss differences in care and outcomes of racial and ethnic minority groups in both of these settings through a review of registries. Furthermore, we explore potential factors that connote a revolving door phenomenon for those whose adverse outpatient environment puts them at risk for hospital readmissions. Additionally, we review promising strategies, as well as actionable items at the policy, clinical, and educational levels aimed at locking this revolving door.
- 18 April 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (8)
Open AccessLocking the Revolving Door: Racial Disparities in Cardiovascular Disease
Racial disparities in cardiovascular disease are unjust, systematic, and preventable. Social determinants are a primary cause of health disparities, and these include factors such as structural and overt racism. Despite a number of efforts implemented over the past several decades, disparities in cardiovascular disease care and outcomes persist, pervading more the outpatient rather than the inpatient setting, thus putting racial and ethnic minority groups at risk for hospital readmissions. In this article, we discuss differences in care and outcomes of racial and ethnic minority groups in both of these settings through a review of registries. Furthermore, we explore potential factors that connote a revolving door phenomenon for those whose adverse outpatient environment puts them at risk for hospital readmissions. Additionally, we review promising strategies, as well as actionable items at the policy, clinical, and educational levels aimed at locking this revolving door.
- 24 May 2022
- Published by Springer Nature in Current Cardiology Reports
- Vol. 24 (7) , 785-792
It Takes a Village: Expanding Women’s Cardiovascular Care to Include the Community as well as Cardiovascular and Primary Care Teams
Purpose of Review Our aim is to highlight some of the current issues that prevent women from getting sex-specific and gender-specific cardiovascular care and provide recommendations for new approaches and delivery models to improve cardiovascular care for all women. Recent Findings Cardiovascular disease remains the number one cause of death for women in the US. Many women remain unaware of cardiovascular risk factors and many healthcare providers who care for women are also poorly informed and feel ill prepared to assess women for cardiovascular risk. Women’s Heart Centers have tried to bridge the gaps in women’s care between primary care and cardiology. Many of the impediments to care in the current models are lack of comprehensive care and socioeconomic societal limitations. Summary New models of care and delivery are essential to change cardiovascular outcomes for all women, especially women at high risk.
- 24 May 2022
- Published by Springer Nature in Current Cardiology Reports
- Vol. 24 (7) , 785-792
It Takes a Village: Expanding Women’s Cardiovascular Care to Include the Community as well as Cardiovascular and Primary Care Teams
Purpose of Review Our aim is to highlight some of the current issues that prevent women from getting sex-specific and gender-specific cardiovascular care and provide recommendations for new approaches and delivery models to improve cardiovascular care for all women. Recent Findings Cardiovascular disease remains the number one cause of death for women in the US. Many women remain unaware of cardiovascular risk factors and many healthcare providers who care for women are also poorly informed and feel ill prepared to assess women for cardiovascular risk. Women’s Heart Centers have tried to bridge the gaps in women’s care between primary care and cardiology. Many of the impediments to care in the current models are lack of comprehensive care and socioeconomic societal limitations. Summary New models of care and delivery are essential to change cardiovascular outcomes for all women, especially women at high risk.
- Open Access
- 1 March 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (5) , e022658
In‐Hospital Complications in Pregnancies Conceived by Assisted Reproductive Technology
Background: Assisted reproductive technology (ART) has emerged as a common treatment option for infertility, a problem that affects an estimated 48 million couples worldwide. Advancing maternal age with increasing prepregnancy cardiovascular risk factors, such as chronic hypertension, obesity, and diabetes, has raised concerns about pregnancy complications associated with ART. However, in‐hospital complications following pregnancies conceived by ART are poorly described. Methods and Results: To assess the patient characteristics, obstetric outcomes, vascular complications and temporal trends of pregnancies conceived by ART, we analyzed hospital deliveries conceived with or without ART between January 1, 2008, and December 31, 2016, from the United States National Inpatient Sample database. We included 106 248 deliveries conceived with ART and 34 167 246 deliveries conceived without ART. Women who conceived with ART were older (35 versus 28 years; P P <0.0001) were incurred compared with women who conceived without ART. Conclusions: Pregnancies conceived by ART have higher risks of adverse obstetric outcomes and vascular complications compared with spontaneous conception. Clinicians should have detailed discussions on the associated complications of ART in women during prepregnancy counseling.
- 1 March 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (5) , e022658
Open AccessIn‐Hospital Complications in Pregnancies Conceived by Assisted Reproductive Technology
Background: Assisted reproductive technology (ART) has emerged as a common treatment option for infertility, a problem that affects an estimated 48 million couples worldwide. Advancing maternal age with increasing prepregnancy cardiovascular risk factors, such as chronic hypertension, obesity, and diabetes, has raised concerns about pregnancy complications associated with ART. However, in‐hospital complications following pregnancies conceived by ART are poorly described. Methods and Results: To assess the patient characteristics, obstetric outcomes, vascular complications and temporal trends of pregnancies conceived by ART, we analyzed hospital deliveries conceived with or without ART between January 1, 2008, and December 31, 2016, from the United States National Inpatient Sample database. We included 106 248 deliveries conceived with ART and 34 167 246 deliveries conceived without ART. Women who conceived with ART were older (35 versus 28 years; P P <0.0001) were incurred compared with women who conceived without ART. Conclusions: Pregnancies conceived by ART have higher risks of adverse obstetric outcomes and vascular complications compared with spontaneous conception. Clinicians should have detailed discussions on the associated complications of ART in women during prepregnancy counseling.
- 1 February 2022
- Published by Elsevier in Endocrine Practice
- Vol. 28 (2) , 199-203
Cardiovascular Disease in Women Update: Ischemia, Diagnostic Testing, and Menopause Hormone Therapy
- 1 February 2022
- Published by Elsevier in Endocrine Practice
- Vol. 28 (2) , 199-203
Cardiovascular Disease in Women Update: Ischemia, Diagnostic Testing, and Menopause Hormone Therapy
- 1 November 2021
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 14 (11) , e007443
Roles and Impact of Journal’s Social Media Editors
- 1 November 2021
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 14 (11) , e007443
Roles and Impact of Journal’s Social Media Editors
- Open Access
- 1 August 2021
- Published by Elsevier in JACC: Case Reports
- Vol. 3 (9) , 1247-1248
Mentors’ Perspectives on Our Commitments to Mentees
- 1 August 2021
- Published by Elsevier in JACC: Case Reports
- Vol. 3 (9) , 1247-1248
Open AccessMentors’ Perspectives on Our Commitments to Mentees
- Open Access
- 2 March 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (5) , e019321
Women in Cardiology Twitter Network: An Analysis of a Global Professional Virtual Community From 2016 to 2019
Background: Social media is an effective channel for the advancement of women physicians; however, its use by women in cardiology has not been systematically studied. Our study seeks to characterize the current Women in Cardiology Twitter network. Methods and Results: Six women‐specific cardiology Twitter hashtags were analyzed: #ACCWIC (American College of Cardiology Women in Cardiology), #AHAWIC (American Heart Association Women in Cardiology), #ilooklikeacardiologist, #SCAIWIN (Society for Cardiovascular Angiography and Interventions Women in Innovations), #WomeninCardiology, and #WomeninEP (Women in Electrophysiology). Twitter data from 2016 to 2019 were obtained from Symplur Signals. Quantitative and descriptive content analyses were performed. The Women in Cardiology Twitter network generated 48 236 tweets, 266 180 903 impressions, and 12 485 users. Tweets increased by 706% (from 2083 to 16 780), impressions by 207% (from 26 755 476 to 82 080 472), and users by 440% (from 796 to 4300), including a 471% user increase internationally. The network generated 6530 (13%) original tweets and 43 103 (86%) amplification tweets. Most original and amplification tweets were authored by women (81% and 62%, respectively) and women physicians (76% and 52%, respectively), with an increase in original and amplification tweets authored by academic women physicians (98% and 109%, respectively) and trainees (390% and 249%, respectively) over time. Community building, professional development, and gender advocacy were the most common tweet contents over the study period. Community building was the most common tweet category for #ACCWIC, #AHAWIC, #ilooklikeacardiologist, #SCAIWIN, and #WomeninCardiology, whereas professional development was most common for #WomeninEP. Conclusions: The Women in Cardiology Twitter network has grown immensely from 2016 to 2019, with women physicians as the driving contributors. This network has become an important channel for community building, professional development, and gender advocacy discussions in an effort to advance women in cardiology.
- 2 March 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (5) , e019321
Open AccessWomen in Cardiology Twitter Network: An Analysis of a Global Professional Virtual Community From 2016 to 2019
Background: Social media is an effective channel for the advancement of women physicians; however, its use by women in cardiology has not been systematically studied. Our study seeks to characterize the current Women in Cardiology Twitter network. Methods and Results: Six women‐specific cardiology Twitter hashtags were analyzed: #ACCWIC (American College of Cardiology Women in Cardiology), #AHAWIC (American Heart Association Women in Cardiology), #ilooklikeacardiologist, #SCAIWIN (Society for Cardiovascular Angiography and Interventions Women in Innovations), #WomeninCardiology, and #WomeninEP (Women in Electrophysiology). Twitter data from 2016 to 2019 were obtained from Symplur Signals. Quantitative and descriptive content analyses were performed. The Women in Cardiology Twitter network generated 48 236 tweets, 266 180 903 impressions, and 12 485 users. Tweets increased by 706% (from 2083 to 16 780), impressions by 207% (from 26 755 476 to 82 080 472), and users by 440% (from 796 to 4300), including a 471% user increase internationally. The network generated 6530 (13%) original tweets and 43 103 (86%) amplification tweets. Most original and amplification tweets were authored by women (81% and 62%, respectively) and women physicians (76% and 52%, respectively), with an increase in original and amplification tweets authored by academic women physicians (98% and 109%, respectively) and trainees (390% and 249%, respectively) over time. Community building, professional development, and gender advocacy were the most common tweet contents over the study period. Community building was the most common tweet category for #ACCWIC, #AHAWIC, #ilooklikeacardiologist, #SCAIWIN, and #WomeninCardiology, whereas professional development was most common for #WomeninEP. Conclusions: The Women in Cardiology Twitter network has grown immensely from 2016 to 2019, with women physicians as the driving contributors. This network has become an important channel for community building, professional development, and gender advocacy discussions in an effort to advance women in cardiology.
- Open Access
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 12
Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use
Women are at increased risk for cardiovascular disease (CVD) compared with men. While traditional risk factors for CVD seem to disproportionately affect women and contribute to this disparity, increased prevalence of CVD at midlife calls into question the contribution of menopause. Given the potential role that declining hormone levels play in this transition, menopause hormone therapies (MHT) have been proposed as a strategy for risk factor reduction. Unfortunately, trials have not consistently shown cardiovascular benefit with use, and several describe significant risks. Notably, the timing of hormone administration seems to play a role in its relative risks and benefits. At present, MHT is not recommended for primary or secondary prevention of CVD. For women who may benefit from the associated vasomotor, genitourinary, and/or bone health properties of MHT, CVD risks should be taken into account prior to administration. Further research is needed to assess routes, dosing, and formulations of MHT in order to elucidate appropriate timing for administration. Here, we aim to review both traditional and sex-specific risk factors contributing to increased CVD risk in women with a focus on menopause, understand cardiovascular effects of MHT through a review of several landmark clinical trials, summarize guidelines for appropriate MHT use, and discuss a comprehensive strategy for reducing CV risk in women.
- 1 January 2021
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 12
Open AccessCardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use
Women are at increased risk for cardiovascular disease (CVD) compared with men. While traditional risk factors for CVD seem to disproportionately affect women and contribute to this disparity, increased prevalence of CVD at midlife calls into question the contribution of menopause. Given the potential role that declining hormone levels play in this transition, menopause hormone therapies (MHT) have been proposed as a strategy for risk factor reduction. Unfortunately, trials have not consistently shown cardiovascular benefit with use, and several describe significant risks. Notably, the timing of hormone administration seems to play a role in its relative risks and benefits. At present, MHT is not recommended for primary or secondary prevention of CVD. For women who may benefit from the associated vasomotor, genitourinary, and/or bone health properties of MHT, CVD risks should be taken into account prior to administration. Further research is needed to assess routes, dosing, and formulations of MHT in order to elucidate appropriate timing for administration. Here, we aim to review both traditional and sex-specific risk factors contributing to increased CVD risk in women with a focus on menopause, understand cardiovascular effects of MHT through a review of several landmark clinical trials, summarize guidelines for appropriate MHT use, and discuss a comprehensive strategy for reducing CV risk in women.